# Immunology of Ebola Vaccine

> **NCT06100913** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Emory University** · enrollment: 30 (actual)

## Conditions studied

- Ebola Virus Disease

## Interventions

- **BIOLOGICAL:** Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)
- **OTHER:** Deuterium Labeled Water

## Key facts

- **NCT ID:** NCT06100913
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-06
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06100913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06100913, "Immunology of Ebola Vaccine". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT06100913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*